| Literature DB >> 32599956 |
Sadanand Pandey1,2,3, Corli De Klerk3, Joonwoo Kim1, Misook Kang2, Elvis Fosso-Kankeu3.
Abstract
Today, the overall occurrence of re-emerging and rising illnesses has been a serious load on economies as well as public health. Here, we describe a simple, nontoxic and eco-friendly method for the synthesis of milk protein (MP)-stabilized silver nanoparticles (MP-s-AgNPs) using ultrahigh-temperature full cream milk. Highly stable AgNPs were prepared with a fair control over their size, without using any reducing or stabilizing agent, and their formation was attributed to the presence of the MP casein. Ag+ ion reduction was possibly caused by the MPs. The synthesized MP-s-AgNPs were characterized in detail by ultraviolet-visible spectroscopy, Fourier-transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, transmission electron microscopy and dynamic light scattering. MP-s-AgNPs showed inhibitory activity against both Gram-positive (Bacillus subtilis and Staphylococcus aureus) and Gram-negative microorganisms (Salmonella typhi and Escherichia coli). Moreover, MP-s-AgNPs were found to be more toxic to bacteria than to fungi (Aspergillus fumigatus, Aspergillus ochraceus and Penicillium chrysogenum).Entities:
Keywords: antimicrobial activity; biopolymer; milk protein; nanotechnology; silver nanoparticles
Year: 2020 PMID: 32599956 PMCID: PMC7362243 DOI: 10.3390/polym12061418
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Photographs of (a) commercial milk and (b) milk protein-stabilized silver nanoparticles (MP-s-AgNPs) solution after 100 min and (c) UV-Vis spectra of MP-s-AgNPs recorded at different time interval. (d) Zeta potential plot for AgNPs produced using milk, showing the excellent stability of MP-s-AgNPs.
Figure 2TEM images of AgNPs synthesized by commercial milk. (a) At lower magnification; (b) at higher magnification; (c) SAED pattern of the AgNPs showing concentric rings indicate the high crystallinity of the NPs and (d) particle size distribution histogram with a Gaussian curve fitting.
Figure 3(a) FTIR spectra of commercial milk (M) and MP-s-AgNPs and (b) shows the X-ray diffraction pattern of commercial milk and MP-s-AgNPs.
Figure 4SEM images of AgNPs synthesized by commercial milk. (a) At lower magnification and (b) at higher magnification and EDS profiles of (c) commercial milk and (d) MP-s-AgNPs.
Figure 5(a) TGA and (b) DTG curves of commercial milk (M) and MP-s-AgNPs.
Figure 6Photos showing disc diffusion test results: inhibition of (a) Escherichia coli and (b) Bacillus subtilis.
Mean values of inhibitory zones generated by the control compound for Gram (+ve) and Gram (−ve) bacteria.
| Bacteria | Control Compound | Zone (mm) | Zone (mm) | Zone (mm) | Zone (mm) | Average Zone (mm) |
|---|---|---|---|---|---|---|
|
| Carbenicillin | 35 | 33 | 36 | 35 | 34.8 ± 1.26 |
|
| 30 | 31 | 28 | 31 | 30.0 ± 1.41 | |
|
| Vancomycin | 18 | 17 | 19 | 19 | 18.3 ± 0.96 |
|
| 25 | 26 | 23 | 25 | 24.8 ± 1.26 |
Mean values and standard error of inhibitory zones generated by the antimicrobial compound for Gram (+ve) and Gram (−ve) bacteria.
| Average Zone (mm) ± Std Error | ||||
|---|---|---|---|---|
| Concentration (µg/disc) |
|
|
|
|
| 800 | 14.8 ± 0.83 | 12.8 ± 0.83 | 11.8 ± 1.09 | 8 ± 0.71 |
| 400 | 9 ± 0.71 | 11.8 ± 0.56 | 13 ± 0.71 | 10.8 ± 1.92 |
| 200 | 8.5 ± 0.50 | 11.3 ± 0.83 | 11 ± 1.87 | 11.5 ± 0.93 |
| 100 | 8.5 ± 0.41 | 11 ± 0.35 | 8 ± 0.71 | 10.3 ± 0.83 |
| 50 | 8.3 ± 0.82 | 10.2 ± 0.89 | 9.5 ± 0.50 | 9.5 ± 0.79 |
| 25 | 7.5 ± 0.50 | 10.7 ± 0.65 | 7.5 ± 0.50 | 8.2 ± 0.89 |
| 12.5 | 7.3 ± 0.43 | 8.8 ± 0.56 | 10.3 ± 0.43 | 10.7 ± 1.19 |
| 6.25 | 7.3 ± 0.25 | 7.7 ± 0.41 | 7.5 ± 0.5 | 7.7 ± 0.41 |
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of the synthesized compound for various bacteria.
| Selected Bacteria | MIC (µg/disc) | MBC (µg/mL) |
|---|---|---|
|
| 800 | 400 |
|
| 800 | 200 |
|
| 400 | 400 |
|
| 200 | 200 |
Minimum inhibition zones generated by the control (reference compound), AmB, for various strains of fungi.
| Fungi | Control Compound | Zone (mm) | Zone (mm) | Zone (mm) | Zone (mm) | Average Zone (mm) |
|---|---|---|---|---|---|---|
|
| Amphotericin B | 8 | 7.5 | 8.5 | 7.5 | 7.88 ± 0.41 |
|
| 14 | 12 | 15 | 12 | 13.25 ± 1.3 | |
|
| 12 | 16 | 17 | 16 | 15.25 ± 1.92 |